Relapsed triple-negative breast cancer: challenges and treatment strategies. - Wikidata - awgldk - TriplyDB

Relapsed triple-negative breast cancer: challenges and treatment strategies.

Relapsed triple-negative breast cancer: challenges and treatment strategies.

http://www.wikidata.org/entity/Q38120666

about

Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition β-Catenin is required for the tumorigenic behavior of triple-negative breast cancer cells.Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatment Doxorubicin-Hyaluronan Conjugated Super-Paramagnetic Iron Oxide Nanoparticles (DOX-HA-SPION) Enhanced Cytoplasmic Uptake of Doxorubicin and Modulated Apoptosis, IL-6 Release and NF-kappaB Activity in Human MDA-MB-231 Breast Cancer Cells.Expression of receptor protein tyrosine phosphatase ζ is a risk factor for triple negative breast cancer relapse Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway.Par-4 prevents breast cancer recurrence Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways.Engineered Breast Cancer Cell Spheroids Reproduce Biologic Properties of Solid Tumors.How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies.

P2860

Q26851765-C24361F5-70DF-451B-B564-22C9772DBB63 Q35058248-7B4510FE-B398-4D3E-89B0-B9826821C7FC Q36020972-22C53EFD-5B59-4D8F-BEE0-BA0C23348634 Q36377493-FAAFB066-AC3A-46BD-87F3-D7541F0B385C Q36524110-58549974-904C-4E38-913A-AA56A1B22FED Q37645090-B3C3CEC7-FADE-4E57-9D21-6CF04CBAD9F5 Q37690031-CCE2BF87-2236-406E-83EC-6AAB6F498FE8 Q38919039-0A85CCAD-8D36-43D9-ADEB-A69D70A50AA9 Q42835560-93F33DA3-6D65-4841-85A9-291B5F9B72A6 Q54965602-BF9045F8-FD27-4969-A0A5-AFE96119267E

P2860

Relapsed triple-negative breast cancer: challenges and treatment strategies.

http://www.wikidata.org/entity/Q38120666

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Relapsed triple-negative breast cancer: challenges and treatment strategies.

@en

type

label

Relapsed triple-negative breast cancer: challenges and treatment strategies.

@en

prefLabel

Relapsed triple-negative breast cancer: challenges and treatment strategies.

@en

P1433

Q38120666-3C1B8A54-D0AF-4AB1-BDA5-F72C81AB0917

P1476

Q38120666-22AD6B34-57F0-4DAD-9525-39FCD9A5ADCF

P2860

Q38120666-02A01725-58FC-4D9B-97EC-4FACF3B54880

Q38120666-04C35BCE-DF6E-4F9B-A4EB-E4D4B65697D7

Q38120666-0B554290-F9A0-44E7-8F92-E7273832A365

Q38120666-11F74A68-A92F-4751-905B-0455F86CF4E5

Q38120666-123959B7-B18C-4123-A3FF-3991CD73719D

Q38120666-19C03352-88C8-4D84-A678-C365B79255C3

Q38120666-1F072428-056F-4904-8A4A-59552D44D237

Q38120666-1FD2783F-7EE6-4A2A-9F69-97E2BA0FCA0E

Q38120666-259B8027-548C-4829-8BE7-956E451C8E19

Q38120666-283F0D72-A1B0-40B9-9FBF-10CAFE64A791

P2888

Q38120666-53B02DE0-0DB5-42B5-83B7-6FA315F2EB18

P304

Q38120666-56AF108B-DFF8-490C-8461-7CFCD0FC8DE6

P31

Q38120666-DCE8CF9C-36C7-45BD-9955-0B72C1F89E1C

P356

Q38120666-2F37849C-1594-4E9C-AEF8-2F75FA830B19

P433

Q38120666-E31D52AA-82AD-4E97-99CF-4EBC55C27A7D

P478

Q38120666-87DA6DCD-18F3-48A0-9DBC-1ED7B9F50587

P50

Q38120666-4FCC8707-7477-4388-A461-BE536337F8D0

Q38120666-6662DD04-617B-4378-BBD5-B582CE920EE6

Q38120666-89E6E256-F1EC-47E5-8B9F-C982D5E8D12F

P577

Q38120666-D714B710-CF22-4F7C-B119-77F97B73BDAB

P6179

Q38120666-D38563DC-657A-455A-9B56-14A9B2A9B8DD

P698

Q38120666-16A61A00-4C30-4425-9E65-78CF51A3635F

P356

S40265-013-0091-6

P1433

P1476

Relapsed triple-negative breast cancer: challenges and treatment strategies.

@en

P2860

Failure of iniparib to inhibit poly(ADP-Ribose) polymerase in vitro

Comprehensive molecular portraits of human breast tumours

Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Hallmarks of 'BRCAness' in sporadic cancers

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Iniparib plus chemotherapy in metastatic triple-negative breast cancer.

Estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 (HER2), and epidermal growth factor receptor expression and benefit from lapatinib in a randomized trial of paclitaxel with lapatinib or placebo as first-line treatme

P2888

s40265-013-0091-6

P304

1257-1265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-013-0091-6

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P50

PierFranco Conte

Maria Vittoria Dieci

Valentina Guarneri

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1010118551

http://www.w3.org/2001/XMLSchema#string

P698

23842749

http://www.w3.org/2001/XMLSchema#string